Key facts
- This page summarizes Sangwoo Park's Form 4 filing for NKGen Biotech, Inc. (NKGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Dec 2023, 21:02.
Sangwoo Park - 13 Dec 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)
- Reporting relationship
- Director, Other*, 10%+ Owner
- Issuer ticker
- NKGN
- Reported as of
- 13 Dec 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Dec 2023, 21:02:22 UTC
- Prior SEC filing
- 10 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Pierre Gagnon, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sangwoo Park filed Form 4 for NKGen Biotech, Inc. (NKGN) on 15 Dec 2023.
Change
- Previous filing in this sequence was filed on 10 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NKGN
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -2,500,000
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 10,120,612
- Date
- 13 Dec 2023
- Ownership
- See footnotes
- Footnotes
- F1, F2
NKGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 397,378
- Date
- 13 Dec 2023
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This statement is filed by NKMax Co., Ltd ("NKMax") and Sangwoo Park ("Mr. Park"). The foregoing persons are hereinafter sometimes referred to as the "Reporting Persons." Mr. Park may be deemed to beneficially own the reported securities by virtue of the fact that Mr. Park has voting and dispositive control over the Issuer's securities held by NKMax.
Footnote F2
The filing of this statement should not be construed as an admission that Mr. Park is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities held by NKMax except to the extent of his pecuniary interest therein.
Footnote F3
These shares are owned directly by Sangwoo Park.
SEC remarks
NKMax may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Park currently serves on the board of directors of the Issuer.